Lonza Benelux
Hoge Mosten 16
4822Nh Breda
NL
Lonza Benelux
Foundation date
1897
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - Analytical services
- #R&D Services - Cell culture
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - CRO (Contract Research Organization)
- #R&D Services - Drug delivery
- #R&D Services - Fill & finish
Lonza is one of the world’s largest companies for contract development and manufacturing, recognized for reliable, high-quality services, regulatory track record, global footprint, innovative technology platforms and over 35 years of experience in mammalian cell culture.
Lonza customers need to maintain high productivity, product quality and reproducibility when moving from the research phase into clinical and commercial manufacturing, rapidly bringing candidates to the clinic and products to market. A successful outcome will often require significant technical expertise and advanced development and manufacturing technologies.
In Lonza’s extensive contract development and manufacturing services portfolio, Lonza uses advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins. Their biologics offering spans from preclinical services, clinical drug product and drug substance and commercial supply in Mammalian, Microbial, ADCs / Bioconjugates, mRNA and Cell & Gene Therapies.
Lonza works in partnership with customers of all sizes, from start-ups to large biotechs and pharmaceutical companies, and can tailor our products and services to your specific needs, budget and timelines
Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
1610 '24
FIGON Dutch Medicines Days
Event by: Hyphen Projects
Latest news
More news-
Scientists discover viral trapdoor blocking HIV and herpes
1 day ago
Read more
-
UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility
Tuesday October 8th 2024
Read more
-
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
Monday October 7th 2024
Read more
Jobs
More jobs-
11/10/24
Flemish Brabant
Model based assessment of spraying techniques for sustainable crop protection (ref. BAP-2024-621)
Temporary
KU Leuven -
10/10/24
Flemish Brabant
Lab & Pilot researcher - Sustainable Chemical Processes (ref. ATP-2024-511)
Temporary
KU Leuven -
10/10/24
East Flanders
Smart Wound Dressings with Diagnostic and Antimicrobial Capabilities (ref. BAP-2024-663)
Temporary
KU Leuven
More info?
Ellen Telleir
Communication Coordinator